Literature DB >> 8850171

The effect of reduced glomerular filtration rate on plasma total homocysteine concentration.

M Arnadottir1, B Hultberg, P Nilsson-Ehle, H Thysell.   

Abstract

The concentration of homocysteine in plasma has been shown to be increased in renal failure, possibly contributing to the accelerated atherosclerosis observed in uraemic patients. The aim of the present study was to document the relationship between plasma total homocysteine (tHcy) concentrations and glomerular filtration rates (GFR) in highly selected patients, with renal function ranging from normal to dialysis dependency. GFR was defined as the plasma clearance of iohexol; a more accurate method than the creatinine-based estimations applied in previous studies. Plasma tHcy concentrations were highly correlated to GFR (r = -0.70, p < 0.0001) and were significantly increased already in moderate renal failure. According to a multiple regression analysis, GFR and red cell folate concentrations independently predicted plasma tHcy concentrations, whereas those of serum creatinine, plasma pyridoxal-5-phosphate, urine albumin and urine alpha-1-microglobulin (a marker of tubular damage) did not. Thus, GFR seems to be a better determinant of plasma tHcy concentration than serum creatinine concentration. Plasma total cysteine and total cysteinylglycine concentrations followed the same pattern as those of tHcy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8850171     DOI: 10.3109/00365519609088586

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  24 in total

Review 1.  Blood levels of homocysteine and atherosclerotic vascular disease.

Authors:  W G Christen; P M Ridker
Journal:  Curr Atheroscler Rep       Date:  2000-05       Impact factor: 5.113

Review 2.  Epidemiology, diagnosis, and management of cardiac disease in chronic renal disease.

Authors:  M J Sarnak; A S Levey
Journal:  J Thromb Thrombolysis       Date:  2000-10       Impact factor: 2.300

3.  Determinants of homocysteine levels in Ivorian rural population.

Authors:  Georges Tiahou; Anne-Marie Dupuy; Isabelle Jaussent; Daniel Sees; Jean-Paul Cristol; Stephanie Badiou
Journal:  Int J Vitam Nutr Res       Date:  2009-09       Impact factor: 1.784

4.  Relationship of serum homocysteine level with nutritional status and HbA1c level in elderly inpatients.

Authors:  Sheng-Fang Chen; Chun-Li Cui; Ping Wu; Nan-Zi Xie
Journal:  Int J Clin Exp Med       Date:  2013-09-25

5.  Associations of Plasma Amino Acid and Acylcarnitine Profiles with Incident Reduced Glomerular Filtration Rate.

Authors:  Feijie Wang; Liang Sun; Qi Sun; Liming Liang; Xianfu Gao; Rongxia Li; An Pan; Huaixing Li; Yueyi Deng; Frank B Hu; Jiarui Wu; Rong Zeng; Xu Lin
Journal:  Clin J Am Soc Nephrol       Date:  2018-03-08       Impact factor: 8.237

6.  Immediate and long-term high levels of plasma homocysteine after extracorporeal shock wave lithotripsy in patients with renal stone disease.

Authors:  Erkan Demir; Volkan Izol; I Atilla Aridogan; Saime Paydas; Zuhtu Tansug; Ugur Erken
Journal:  Clin Exp Nephrol       Date:  2014-05-28       Impact factor: 2.801

Review 7.  Homocysteine and blood pressure.

Authors:  Coen van Guldener; Prabath W B Nanayakkara; Coen D A Stehouwer
Journal:  Curr Hypertens Rep       Date:  2003-02       Impact factor: 5.369

Review 8.  [Atherosclerosis and uremia: signifance of non-traditional risk factors].

Authors:  Walter H Hörl
Journal:  Wien Klin Wochenschr       Date:  2003-04-30       Impact factor: 1.704

9.  Selected physiologic variables are weakly to moderately associated with 29 biomarkers of diet and nutrition, NHANES 2003-2006.

Authors:  Bridgette M H Haynes; Christine M Pfeiffer; Maya R Sternberg; Rosemary L Schleicher
Journal:  J Nutr       Date:  2013-04-17       Impact factor: 4.798

10.  Homocysteine induced cardiovascular events: a consequence of long term anabolic-androgenic steroid (AAS) abuse.

Authors:  M R Graham; F M Grace; W Boobier; D Hullin; A Kicman; D Cowan; B Davies; J S Baker
Journal:  Br J Sports Med       Date:  2006-02-17       Impact factor: 13.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.